Allison W. Kurian, M.D., M.Sc.

Publications

• Multigene Panel Testing in Oncology Practice: How Should We Respond?
  Kurian, A. W., & Ford, J. M. (2015). Multigene Panel Testing in Oncology Practice: How Should We Respond?. JAMA oncology, 1(3), 277-278.
• Precision Medicine in Breast Cancer Care: An Early Glimpse of Impact.
  Kurian, A. W., & Friese, C. R. (2015). Precision Medicine in Breast Cancer Care: An Early Glimpse of Impact. JAMA oncology.
• Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations.
  Katz, S. J., Kurian, A. W., & Morrow, M. (2015). Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations. JAMA.
• Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. Kurian, A. W., Lichtensztajn, D. Y., Keegan, T. Hm., Nelson, D. O., Clarke, C. A., & Gomez, S. L. (2014). Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. JAMA-the journal of the American Medical Association, 312(9), 902-914.
  
• Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., & Ford, J. M. (2014). Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment. JOURNAL OF CLINICAL ONCOLOGY, 32(19), 2001-2009.
  
• Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research. Kurian, A. W., Mitani, A., Desai, M., Yu, P. P., Seto, T., & Das, A. K. (2014). Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research. Cancer, 120(1), 103-111.
  
• Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007 Kurian, A. W., Lichtensztajn, D. Y., Keegan, T. Hm., Leung, R. W., Shema, S. J., & Gomez, S. L. (2013). Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. BREAST CANCER RESEARCH AND TREATMENT, 137(1), 247-260.
  
• Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers Kurian, A. W., Munoz, D. F., Rust, P., Schackmann, E. A., Smith, M., & Plevritis, S. K. (2012). Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers. JOURNAL OF CLINICAL ONCOLOGY, 30(5), 497-506.
  
• Oncoshare: lessons learned from building an integrated multi-institutional database for comparative effectiveness research. Weber, S. C., Seto, T., Olson, C., Kenkare, P., Kurian, A. W., & Das, A. K. (2012). Oncoshare: lessons learned from building an integrated multi-institutional database for comparative effectiveness research. AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium, 2012, 970-978.
  
• Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry Kurian, A. W., Gong, G. D., John, E. M., Johnston, D. A., Felberg, A., & Whittemore, A. S. (2011). Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry. JOURNAL OF CLINICAL ONCOLOGY, 29(34), 4505-4509.
  
• Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers Kurian, A. W., Sigal, B. M., & Plevritis, S. K. (2010). Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers. JOURNAL OF CLINICAL ONCOLOGY, 28(2), 222-231.
  
• Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups Kurian, A. W., Fish, K., Shema, S. J., & Clarke, C. A. (2010). Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. BREAST CANCER RESEARCH, 12(6).
  
• Second Primary Breast Cancer Occurrence According to Hormone Receptor Status Kurian, A. W., McClure, L. A., John, E. M., Horn-Ross, P. L., Ford, J. M., & Clarke, C. A. (2009). Second Primary Breast Cancer Occurrence According to Hormone Receptor Status. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 101(15), 1058-1065.
  
• Performance of BRCA1/2 mutation prediction models in Asian Americans Kurian, A. W., Gong, G. D., Chun, N. M., Mills, M. A., Staton, A. D., & Ford, J. M. (2008). Performance of BRCA1/2 mutation prediction models in Asian Americans. JOURNAL OF CLINICAL ONCOLOGY, 26(29), 4752-4758.
  
• A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer Kurian, A. W., Newton Thompson, R., Gaw, A. F., Arai, S., Ortiz, R., & Garber, A. M. (2007). A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 25(6), 634-641.
  
• Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging Plevritis, S. K., Kurian, A. W., Sigal, B. M., Daniel, B. L., Ikeda, D. M., & Garber, A. M. (2006). Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 295(20), 2374-2384.
  
• Histologic types of epithelial ovarian cancer: have they different risk factors? Kurian, A. W., Balise, R. R., McGuire, V., & Whittemore, A. S. (2005). Histologic types of epithelial ovarian cancer: have they different risk factors?. GYNECOLOGIC ONCOLOGY, 96(2), 520-530.
  
• Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer. Shariff-Marco, S., Yang, J., John, E. M., Kurian, A. W., Cheng, I., & Gomez, S. L. (2015). Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer. Journal of community health, 40(6), 1287-1299.
  
• Navigating choices when applying multiple imputation in the presence of multi-level categorical interaction effects Mitani, A. A., Kurian, A. W., Das, A. K., & Desai, M. (2015). Navigating choices when applying multiple imputation in the presence of multi-level categorical interaction effects. STATISTICAL METHODOLOGY, 27, 82-99.
  
• Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. Desmond, A., Kurian, A. W., Gabree, M., Mills, M. A., Anderson, M. J., & Ellisen, L. W. (2015). Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. JAMA oncology.
  
• A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients Lincoln, S. E., Kobayashi, Y., Anderson, M. J., Yang, S., Desmond, A. J., & Ellisen, L. W. (2015). A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients. JOURNAL OF MOLECULAR DIAGNOSTICS, 17(5), 533-544.
  
• Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer Afghahi, A., Forgo, E., Mitani, A. A., Desai, M., Varma, S., & West, R. B. (2015). Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer. BREAST CANCER RESEARCH, 17.
  
• Contribution of the Neighborhood Environment and Obesity to Breast Cancer Survival: The California Breast Cancer Survivorship Consortium Cheng, I., Shariff-Marco, S., Koo, J., Monroe, K. R., Yang, J., & Keegan, T. Hm. (2015). Contribution of the Neighborhood Environment and Obesity to Breast Cancer Survival: The California Breast Cancer Survivorship Consortium. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 24(8), 1282-1290.
  
• Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study Tao, L., Gomez, S. L., Keegan, T. Hm., Kurian, A. W., & Clarke, C. A. (2015). Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 24(7), 1039-1045.
  
• Breast Cancer Risk Reduction, Version 2.2015 Bevers, T. B., Ward, J. H., Arun, B. K., Colditz, G. A., Cowan, K. H., & Kumar, R. (2015). Breast Cancer Risk Reduction, Version 2.2015. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 13(7), 880-915.
  
• History of Recreational Physical Activity and Survival After Breast Cancer The California Breast Cancer Survivorship Consortium Lu, Y., John, E. M., Sullivan-Halley, J., Vigen, C., Gomez, S. L., & Bernstein, L. (2015). History of Recreational Physical Activity and Survival After Breast Cancer The California Breast Cancer Survivorship Consortium. AMERICAN JOURNAL OF EPIDEMIOLOGY, 181(12), 944-955.
  
• Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105 Telli, M. L., Jensen, K. C., Vinayak, S., Kurian, A. W., Lipson, J. A., & Ford, J. M. (2015). Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105. JOURNAL OF CLINICAL ONCOLOGY, 33(17), 1895-U57.
  
• Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. Jagsi, R., Griffith, K. A., Kurian, A. W., Morrow, M., Hamilton, A. S., & Hawley, S. T. (2015). Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. Journal of clinical oncology , 33(14), 1584-1591.
  
• Racial/Ethnic and Socioeconomic Differences in Short-Term Breast Cancer Survival Among Women in an Integrated Health System Keegan, T. Hm., Kurian, A. W., Gali, K., Tao, L., Lichtensztajn, D. Y., & Gomez, S. L. (2015). Racial/Ethnic and Socioeconomic Differences in Short-Term Breast Cancer Survival Among Women in an Integrated Health System. AMERICAN JOURNAL OF PUBLIC HEALTH, 105(5), 938-946.
  
• How can we best respect patient autonomy in breast cancer treatment decisions? Martinez, K. A., Kurian, A. W., Hawley, S. T., & Jagsi, R. How can we best respect patient autonomy in breast cancer treatment decisions?. Breast cancer management, 4(1), 53-64.
  
• Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment Kurian, A. W., Kingham, K. E., & Ford, J. M. (2015). Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 27(1), 23-33.
  
• Diabetes and Other Comorbidities in Breast Cancer Survival by Race/Ethnicity: The California Breast Cancer Survivorship Consortium (CBCSC) Wu, A. H., Kurian, A. W., Kwan, M. L., John, E. M., Lu, Y., & Vigen, C. (2015). Diabetes and Other Comorbidities in Breast Cancer Survival by Race/Ethnicity: The California Breast Cancer Survivorship Consortium (CBCSC). CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 24(2), 361-368.
  
• Linking electronic health records to better understand breast cancer patient pathways within and between two health systems Thompson, C. A., Kurian, A. W., & Luft, H. S. (2015). Linking electronic health records to better understand breast cancer patient pathways within and between two health systems. eGEMs (Generating Evidence & Methods to improve patient outcomes), 3(1).
  
• Reply to S.M. Sorscher and A.B. Hafeez Bhatti. Jagsi, R., Griffith, K. A., Kurian, A. W., Morrow, M., Hamilton, A. S., & Hawley, S. T. (2015). Reply to S.M. Sorscher and A.B. Hafeez Bhatti. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
  
• Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. Kwong, A., Shin, V. Y., Ho, J. C., Kang, E., Nakamura, S., & Kim, S. W. (2015). Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. Journal of medical genetics.
  
• Multiple-Gene Panels and the Future of Genetic Testing Kurian, A. W., & Ford, J. M. (2015). Multiple-Gene Panels and the Future of Genetic Testing. Current Breast Cancer Reports.
  
• Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 1.2014 Daly, M. B., Pilarski, R., Axilbund, J. E., Buys, S. S., Crawford, B., & Kumar, R. (2014). Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 1.2014. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 12(9), 1326-1338.
  
• Response. Price, E. R., Hargreaves, J., Lipson, J. A., Sickles, E. A., Brenner, R. J., & Ikeda, D. M. (2014). Response. Radiology, 271(3), 927-928.
  
• Beyond barriers: fundamental 'disconnects' underlying the treatment of breast cancer patients' sexual health Halley, M. C., May, S. G., Rendle, K. As., Frosch, D. L., & Kurian, A. W. (2014). Beyond barriers: fundamental 'disconnects' underlying the treatment of breast cancer patients' sexual health. CULTURE HEALTH & SEXUALITY, 16(9), 1169-1180.
  
• Obesity and Mortality After Breast Cancer by Race/Ethnicity: The California Breast Cancer Survivorship Consortium Kwan, M. L., John, E. M., Caan, B. J., Lee, V. S., Bernstein, L., & Wu, A. H. (2014). Obesity and Mortality After Breast Cancer by Race/Ethnicity: The California Breast Cancer Survivorship Consortium. AMERICAN JOURNAL OF EPIDEMIOLOGY, 179(1), 95-111.
  
• The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival Wu, A. H., Gomez, S. L., Vigen, C., Kwan, M. L., Keegan, T. Hm., & Sposto, R. (2013). The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. CANCER CAUSES & CONTROL, 24(10), 1821-1836.
  
• A Population-Based Observational Study of First-Course Treatment and Survival for Adolescent and Young Adult Females with Breast Cancer DeRouen, M. C., Gomez, S. L., Press, D. J., Tao, L., Kurian, A. W., & Keegan, T. Hm. (2013). A Population-Based Observational Study of First-Course Treatment and Survival for Adolescent and Young Adult Females with Breast Cancer. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2(3), 95-103.
  
• A Young Woman With Bilateral Breast Cancer: Identifying a Genetic Cause and Implications for Management de Bruin, M. A., Ford, J. M., & Kurian, A. W. (2013). A Young Woman With Bilateral Breast Cancer: Identifying a Genetic Cause and Implications for Management. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 11(5), 512-517.
  
• Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers Schackmann, E. A., Munoz, D. F., Mills, M. A., Plevritis, S. K., & Kurian, A. W. (2013). Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers. FAMILIAL CANCER, 12(1), 65-73.
  
• The California Breast Density Information Group: A Collaborative Response to the Issues of Breast Density, Breast Cancer Risk, and Breast Density Notification Legislation Price, E. R., Hargreaves, J., Lipson, J. A., Sickles, E. A., Brenner, R. J., & Ikeda, D. M. (2013). The California Breast Density Information Group: A Collaborative Response to the Issues of Breast Density, Breast Cancer Risk, and Breast Density Notification Legislation. RADIOLOGY.
  
• Information technology interventions to improve cancer care: a report from the American Society of Clinical Oncology Quality Care Symposium Kurian, A. W., & Edge, S. B. (2013). Information technology interventions to improve cancer care: a report from the American Society of Clinical Oncology Quality Care Symposium. JOURNAL OF ONCOLOGY PRACTICE, 9(3).
  
• A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk Vinayak, S., Schwartz, E. J., Jensen, K., Lipson, J., Alli, B., & Kurian, A. W. (2013). A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk. BREAST CANCER RESEARCH AND TREATMENT, electronic publication ahead of print, October 30.
  
• Impact of breast cancer subtypes on three-year survival among adolescent and young adult women Keegan, T. Hm., Press, D. J., Tao, L., DeRouen, M. C., Kurian, A. W., & Gomez, S. L. (2013). Impact of breast cancer subtypes on three-year survival among adolescent and young adult women. BREAST CANCER RESEARCH, 15(5).
  
• Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients Kwong, A., Ng, E. Ko., Law, F. Bf., Wong, H. N., Wa, A., & Ma, E. Sk. (2012). Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients. BREAST CANCER RESEARCH AND TREATMENT, 136(3), 931-933.
  
• Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis Kwong, A., Ng, E. K. O., Wong, C. L. P., Law, F. B. F., Au, T., & Ma, E. S. K. (2012). Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis. PLOS ONE, 7(9).
  
• Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations de Bruin, M. A., Kwong, A., Goldstein, B. A., Lipson, J. A., Ikeda, D. M., & Kurian, A. W. (2012). Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations. FAMILIAL CANCER, 11(3), 429-439.
  
• A Simulation Model to Predict the Impact of Prophylactic Surgery and Screening on the Life Expectancy of BRCA1 and BRCA2 Mutation Carriers Sigal, B. M., Munoz, D. F., Kurian, A. W., & Plevritis, S. K. (2012). A Simulation Model to Predict the Impact of Prophylactic Surgery and Screening on the Life Expectancy of BRCA1 and BRCA2 Mutation Carriers. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 21(7), 1066-1077.
  
• Age-Specific Incidence of Breast Cancer Subtypes: Understanding the BlackWhite Crossover Clarke, C. A., Keegan, T. Hm., Yang, J., Press, D. J., Kurian, A. W., & Lacey, J. V. (2012). Age-Specific Incidence of Breast Cancer Subtypes: Understanding the BlackWhite Crossover. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 104(14), 1094-1101.
  
• Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines Powell, A. A., Talasaz, Aa. H., Zhang, H., Coram, M. A., Reddy, A., & Jeffrey, S. S. (2012). Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines. PLOS ONE, 7(5).
  
• Patient, Hospital, and Neighborhood Factors Associated with Treatment of Early-Stage Breast Cancer among Asian American Women in California Gomez, S. L., Press, D. J., Lichtensztajn, D., Keegan, T. Hm., Shema, S. J., & Kurian, A. W. (2012). Patient, Hospital, and Neighborhood Factors Associated with Treatment of Early-Stage Breast Cancer among Asian American Women in California. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 21(5), 821-834.
  
• Accuracy of BRCA1/2 Mutation Prediction Models for Different Ethnicities and Genders: Experience in a Southern Chinese Cohort Kwong, A., Wong, C. Hn., Suen, D. Tk., Co, M., Kurian, A. W., & Ford, J. M. (2012). Accuracy of BRCA1/2 Mutation Prediction Models for Different Ethnicities and Genders: Experience in a Southern Chinese Cohort. WORLD JOURNAL OF SURGERY, 36(4), 702-713.
  
• In reply to "Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: More Trouble With Phenocopies" by Evans et al Kurian, A. W., & Whittemore, A. S. (2012). In reply to "Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: More Trouble With Phenocopies" by Evans et al. JOURNAL OF CLINICAL ONCOLOGY, 30.
  
• Genetic Polymorphisms as Predictors of Breast Cancer Risk de Bruin, M. A., Ford, J. M., & Kurian, A. W. (2012). Genetic Polymorphisms as Predictors of Breast Cancer Risk. CURRENT BREAST CANCER REPORTS.
  
• Occurrence of breast cancer subtypes in adolescent and young adult women Keegan, T. Hm., DeRouen, M. C., Press, D. J., Kurian, A. W., & Clarke, C. A. (2012). Occurrence of breast cancer subtypes in adolescent and young adult women. BREAST CANCER RESEARCH, 14(2).
  
• A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer Chen, Y., Kingham, K., Ford, J. M., Rosing, J., Van Dam, J., & Norton, J. A. (2011). A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer. ANNALS OF SURGICAL ONCOLOGY, 18(9), 2594-2598.
  
• Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry Telli, M. L., Chang, E. T., Kurian, A. W., Keegan, T. Hm., McClure, L. A., & Gomez, S. L. (2011). Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. BREAST CANCER RESEARCH AND TREATMENT, 127(2), 471-478.
  
• Hereditary cancer: counseling women at risk Lebensohn, A. P., Kingham, K. E., Chun, N. M., & Kurian, A. W. (2011). Hereditary cancer: counseling women at risk. CONTEMPORARY OBSTETRICS AND GYNECOLOGY, 56(4).
  
• High-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese breast cancer patients Kwong, A., Ng, E. Ko., Law, F. Bf., Wong, L. P., To, M. Y., & Ma, E. Sk. (2010). High-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese breast cancer patients. BREAST CANCER RESEARCH AND TREATMENT, 122(2), 605-607.
  
• Genetic/familial high-risk assessment: breast and ovarian. Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., & Weitzel, J. N. (2010). Genetic/familial high-risk assessment: breast and ovarian. Journal of the National Comprehensive Cancer Network , 8(5), 562-594.
  
• Increasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California Gomez, S. L., Lichtensztajn, D., Kurian, A. W., Telli, M. L., Chang, E. T., & Clarke, C. A. (2010). Increasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California. JOURNAL OF CLINICAL ONCOLOGY, 28(10), E155-E157.
  
• BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications Kurian, A. W. (2010). BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 22(1), 72-78.
  
• Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry Kurian, A. W., Gong, G. D., John, E. M., Miron, A., Felberg, A., & Whittemore, A. S. (2009). Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 18(4), 1084-1091.
  
• In reply to 'Tailoring BRCRAPRO to Asian Americans?' by S. Chen et al Kurian, A. W., Whittemore, A. S., & Ford, J. M. (2009). In reply to 'Tailoring BRCRAPRO to Asian Americans?' by S. Chen et al. JOURNAL OF CLINICAL ONCOLOGY, 27.
  
• The Decline in Breast Cancer Incidence: Real or Imaginary? Kurian, A. W., Clarke, C. A., & Carlson, R. W. (2009). The Decline in Breast Cancer Incidence: Real or Imaginary?. CURRENT ONCOLOGY REPORTS, 11(1), 21-28.
  
• Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease. Vinayak, S., & Kurian, A. W. (2009). Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease. Current breast cancer reports, 1(3), 148-156.
  
• Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers Staton, A. D., Kurian, A. W., Cobb, K., Mills, M. A., & Ford, J. M. (2008). Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. FAMILIAL CANCER, 7(2), 179-186.
  
• Magnetic resonance galactography: A feasibility study in women with prior atypical breast duct cytology Kurian, A. W., Hartman, A.-R., Mills, M. A., Logan, L. J., Sawyer, A. M., & Daniel, B. L. (2008). Magnetic resonance galactography: A feasibility study in women with prior atypical breast duct cytology. BREAST JOURNAL, 14(2), 211-214.
  
• A carrier of both MEN1 and BRCA2 mutations: case report a-lid review of the literature Ghataorhe, P., Kurian, A. W., Pickart, A., Trapane, P., Norton, J. A., & Ford, J. M. (2007). A carrier of both MEN1 and BRCA2 mutations: case report a-lid review of the literature. CANCER GENETICS AND CYTOGENETICS, 179(2), 89-92.
  
• CDH1 truncating mutations in the E-cadherin gene - An indication for total gastrectomy to treat hereditary diffuse gastric cancer Norton, J. A., Ham, C. M., Van Dam, J., Jeffrey, R. B., Longacre, T. A., & Ford, J. M. (2007). CDH1 truncating mutations in the E-cadherin gene - An indication for total gastrectomy to treat hereditary diffuse gastric cancer. ANNALS OF SURGERY, 245(6), 873-879.
  
• Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage Ghanouni, P., Kurian, A. W., Margolis, D., Hartman, A.-R., Mills, M. A., & Daniel, B. L. (2007). Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage. BREAST JOURNAL, 13(3), 281-286.
  
• Biomedical terahertz imaging with a quantum cascade laser Kim, S. M., Hatami, F., Harris, J. S., Kurian, A. W., Ford, J., & Harris, G. (2006). Biomedical terahertz imaging with a quantum cascade laser. APPLIED PHYSICS LETTERS, 88(15).
  
• Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage Kurian, A. W., Hartman, A. R., Mills, M. A., Ford, J. M., Daniel, B. L., & Plevritis, S. K. (2005). Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. HEALTH EXPECTATIONS, 8(3), 221-233.
  
• Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk Kurian, A. W., Mills, M. A., Jaffee, M., Sigal, B. M., Chun, N. M., & Hartman, A. R. (2005). Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 14(5), 1082-1089.
  
• Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma Hartman, A. R., Daniel, B. L., Kurian, A. W., Mills, M. A., Nowels, K. W., & Plevritis, S. K. (2004). Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma. CANCER, 100(3), 479-489.